These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19903008)

  • 21. iPSC in the past decade: the Japanese dominance.
    Ilic D
    Regen Med; 2016 Dec; 11(8):747-749. PubMed ID: 27885898
    [No Abstract]   [Full Text] [Related]  

  • 22. [An introduction to stem cell research].
    Jensen PL; Wegeberg JP; Andersen CY
    Ugeskr Laeger; 2010 Sep; 172(38):2594-7. PubMed ID: 20920401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global challenges in stem cell research and the many roads ahead.
    Sipp D
    Neuron; 2011 May; 70(4):573-6. PubMed ID: 21609815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research.
    Roncalli JG; Tongers J; Renault MA; Losordo DW
    Trends Biotechnol; 2008 May; 26(5):276-83. PubMed ID: 18359114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regenerative medicine, resource and regulation: lessons learned from the remedi project.
    Ginty PJ; Rayment EA; Hourd P; Williams DJ
    Regen Med; 2011 Mar; 6(2):241-53. PubMed ID: 21391857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. California prepares to roll out stem-cell funding.
    Dalton R
    Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
    [No Abstract]   [Full Text] [Related]  

  • 27. Cultivating regenerative medicine innovation in China.
    McMahon DS; Thorsteinsdóttir H; Singer PA; Daar AS
    Regen Med; 2010 Jan; 5(1):35-44. PubMed ID: 20055687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regenerative medicine: learning from past examples.
    Couto DS; Perez-Breva L; Cooney CL
    Tissue Eng Part A; 2012 Nov; 18(21-22):2386-93. PubMed ID: 22697402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NIH and the regenerative medicine field.
    Rao M
    Regen Med; 2012 Mar; 7(2):129-31. PubMed ID: 22397601
    [No Abstract]   [Full Text] [Related]  

  • 30. The economic value of investing in regenerative medicine.
    Hussain A; Rivers PA
    J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the stem cell and regenerative medicine industry.
    Ilic D
    Regen Med; 2012 Sep; 7(5):645-8. PubMed ID: 22954435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amniotic fluid-derived stem cells in regenerative medicine research.
    Joo S; Ko IK; Atala A; Yoo JJ; Lee SJ
    Arch Pharm Res; 2012 Feb; 35(2):271-80. PubMed ID: 22370781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State stem cell agency floats idea of $70 million 'Alpha' clinics.
    Dolgin E
    Nat Med; 2013 Jul; 19(7):798. PubMed ID: 23836206
    [No Abstract]   [Full Text] [Related]  

  • 34. The World Stem Cell Summit. Interview with Bernard Siegel.
    Siegel B
    Regen Med; 2011 Nov; 6(6 Suppl):109-12. PubMed ID: 21999271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early evaluation and value-based pricing of regenerative medicine technologies.
    Koerber F; Rolauffs B; Rogowski W
    Regen Med; 2013 Nov; 8(6):747-58. PubMed ID: 24147530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem-cell research: after the gold rush.
    Aldhous P
    Nature; 2005 Apr; 434(7034):694-6. PubMed ID: 15815600
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR; Passier R; Mummery CL
    Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential.
    Prakash S; Khan A; Paul A
    Expert Opin Biol Ther; 2010 Dec; 10(12):1649-61. PubMed ID: 20954792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. California institute to help stem-cell biotechs.
    Hayden EC
    Nature; 2008 Sep; 455(7212):436-7. PubMed ID: 18818612
    [No Abstract]   [Full Text] [Related]  

  • 40. Industry concerns mount over CIRM grants.
    Baker M
    Nat Biotechnol; 2007 Oct; 25(10):1063-4. PubMed ID: 17921974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.